The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review
- 21 April 2016
- journal article
- review article
- Published by Elsevier BV in Clinical Genitourinary Cancer
- Vol. 14 (6), 473-484
- https://doi.org/10.1016/j.clgc.2016.04.008
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Preoperative Neutrophil-Lymphocyte Ratio as an Independent Prognostic Marker for Patients With Upper Urinary Tract Urothelial CarcinomaClinical Genitourinary Cancer, 2013
- Preoperative Neutrophil/Lymphocyte Ratio Predicts Overall Survival and Extravesical Disease in Patients Undergoing Radical CystectomyJournal of Endourology, 2013
- Can Neutrophil-Lymphocyte Ratio and Lymph Node Density Be Used as Prognostic Factors in Patients Undergoing Radical Cystectomy?The Scientific World Journal, 2013
- Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients Presenting With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionThe American Journal of Cardiology, 2013
- Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical CystectomyUrology, 2012
- UROLOGICAL ONCOLOGY Serum C-reactive protein level is a significant prognostic indicator in patients with advanced urothelial cancer treated with gemcitabine-cisplatin or carboplatin – preliminary resultsCentral European Journal of Urology, 2012
- Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?Trends in Immunology, 2009
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis: Integrative Cancer Research, 2009
- Inflammation and cancerNature, 2002